Anaphylaxis
Anaphylaxis kills by airway oedema, bronchospasm and distributive shock — sometimes all three in the same patient. Intramuscular adrenaline into the anterolateral thigh is the only intervention proven to reduce mortality; everything else is adjunctive.
On this page01 · Recognising anaphylaxis — when to commit
Recognising anaphylaxis — when to commit
Anaphylaxis is highly likely when any one of three clinical patterns is present. Do not wait for hypotension — skin plus airway, or skin plus breathing, is enough.
Bedside key actions
- ERC 2025 + RC UK 2025 explicitly advise against routine corticosteroids — strengthens prior 2021 position
- Refractory anaphylaxis: ECPR is now an option in centres where available (ERC 2025 Special Circumstances)
First-line treatment — adrenaline IM
Five things, in this order. Adrenaline IM is the only drug that changes mortality. Antihistamines and steroids are adjuncts — they do not treat the airway or shock.
Bedside key actions
What NOT to lead with — common errors
These are the recurring mistakes that turn a survivable anaphylaxis into a death. Each one delays or replaces IM adrenaline.
Bedside key actions
Refractory anaphylaxis — when 2 IM doses are not enough
Defined as persistent symptoms after 2 appropriate IM doses. Move to an adrenaline infusion and call for senior airway and ICU support early.
Bedside key actions
Observation, biphasic risk and discharge
Every patient gets a minimum observation period stratified by severity. Discharge is conditional on adrenaline auto-injector, written plan, and allergy follow-up.
Bedside key actions
Key takeaways
- Adrenaline 0.5 mg IM into the anterolateral thigh is the only intervention that changes mortality. Give it the moment criteria are met — do not wait for hypotension.
- Up to 1 in 5 patients have no skin signs. Sudden bronchospasm or hypotension after a likely allergen is anaphylaxis until proven otherwise.
- Steroids and antihistamines treat the rash and the itch, not the airway or the shock. They are adjuncts and have no role in the first five minutes.
- Refractory anaphylaxis (still unwell after 2 IM doses) needs an adrenaline infusion, not more boluses — and glucagon if the patient is on a beta blocker.
- Discharge requires two auto-injectors, a written action plan, demonstrated technique, and an allergy clinic referral. Without these, the next reaction is the fatal one.
References
Freely citableEvery clinical claim in this chapter is backed by an independent, freely-accessible guideline. Tap any reference to open the source on the issuing body's site.
- RC UK 2025 AnaphylaxisUK
Resuscitation Council UK 2025 — Emergency treatment of anaphylaxis: guidelines for healthcare providers
“Adrenaline should be given as soon as the diagnosis of anaphylaxis is suspected. The intramuscular route is recommended for most healthcare providers.”
Open source ↗
- NICE CG134 (2020 update)UK
Anaphylaxis: assessment and referral after emergency treatment
Open source ↗
- WAO 2020Global
World Allergy Organization Anaphylaxis Guidance 2020
Open source ↗
- ERC 2025Europe
European Resuscitation Council Guidelines 2025 — Cardiac Arrest in Special Circumstances (anaphylaxis)
Open source ↗
- ICMR STWIndia
Indian Council of Medical Research — Standard Treatment Workflow: Anaphylaxis
Open source ↗
- Indian Academy of Allergy & Asthma — Anaphylaxis (2023)India
IAAA position statement on anaphylaxis recognition and adrenaline use
Open source ↗
Test yourself
CME · 5 vignettesClinical vignettes built from this chapter. Pass ≥70% to earn a printable 0.5 CME certificate.
Sign in to take the quiz and earn a certificate.
Compiled from contemporary emergency-medicine practice and the guidelines listed above. For registered medical practitioners; not a substitute for clinical judgement.
Study with Dr Sumit
Like this chapter? There are 295 more.
Visual ED study chapters across resuscitation, trauma, cardiovascular, respiratory, neurology, toxicology, paediatrics and more — all built for working clinicians in Indian EDs and beyond. Plus calculators, decision rules, and clinical algorithms.
No clinical decisions should rest on a single source — always cross-check with local protocols. Educational use only.